Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity
- PMID: 8392322
- DOI: 10.1007/BF01379080
Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity
Abstract
Thymidine kinase (TK) of herpes simplex virus (HSV) has been identified as one of the factors responsible for its virulence. We have previously isolated acyclovir (ACV)-resistant HSV type 2 (HSV-2), strain YS-4 C-1, by simple plaque cloning from a clinical isolate. Although YS-4 C-1 had extremely low TK activity, it retained high virulence in mice. To determine the mechanism of the reduction of TK activity, a molecular analysis of the YS-4 C-1 TK gene was performed. YS-4 C-1 produced TK mRNA, which was indistinguishable both in size and amount from that of wild-type strains. However, the YS-4 C-1 TK had a single amino acid change from serine to asparagine at amino acid residue 182 of the TK polypeptide, which was caused by a single nucleotide mutation. It was situated within a highly conserved region (162-194) and close to the putative nucleoside-binding site (169-177), one of the three active centers of TK. In order to confirm the effect of this missense mutation on both the TK activity and neurovirulence, the mutation was introduced into the TK genes of wild-type strains. Although all the recombinants were altered to ACV-resistant viruses with reduced TK activity, they retained high neurovirulence for mice. Our study thus suggested that this mutant TK, in spite of low activity, might play a role in the neurovirulence of HSV-2.
Similar articles
-
An acyclovir-resistant strain of herpes simplex virus type 2 which is highly virulent for mice.Arch Virol. 1988;101(3-4):169-82. doi: 10.1007/BF01310998. Arch Virol. 1988. PMID: 2845890
-
Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.Antimicrob Agents Chemother. 1987 Oct;31(10):1483-90. doi: 10.1128/AAC.31.10.1483. Antimicrob Agents Chemother. 1987. PMID: 2829709 Free PMC article.
-
Phenotypic and genotypic characterization of clinical isolates of herpes simplex virus resistant to aciclovir.J Gen Virol. 2003 Jun;84(Pt 6):1393-1401. doi: 10.1099/vir.0.18880-0. J Gen Virol. 2003. PMID: 12771406
-
Acyclovir-resistant, pathogenic herpesviruses.Trends Microbiol. 1994 Dec;2(12):481-5. doi: 10.1016/0966-842x(94)90652-1. Trends Microbiol. 1994. PMID: 7889324 Review.
-
Viral thymidine kinases and their relatives.Pharmacol Ther. 1992;54(3):319-55. doi: 10.1016/0163-7258(92)90006-l. Pharmacol Ther. 1992. PMID: 1334563 Review.
Cited by
-
Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.Antimicrob Agents Chemother. 2011 Feb;55(2):459-72. doi: 10.1128/AAC.00615-10. Epub 2010 Nov 15. Antimicrob Agents Chemother. 2011. PMID: 21078929 Free PMC article. Review.
-
Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.J Virol. 1997 May;71(5):3872-8. doi: 10.1128/JVI.71.5.3872-3878.1997. J Virol. 1997. PMID: 9094663 Free PMC article.
-
Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.J Clin Microbiol. 2010 Oct;48(10):3496-503. doi: 10.1128/JCM.01263-10. Epub 2010 Aug 11. J Clin Microbiol. 2010. PMID: 20702659 Free PMC article. Clinical Trial.
-
Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.J Clin Microbiol. 2000 May;38(5):1839-44. doi: 10.1128/JCM.38.5.1839-1844.2000. J Clin Microbiol. 2000. PMID: 10790110 Free PMC article.